Extracellular-signal-regulated-kinase (ERK) heteropolyligand polypeptide
US8283445B2 · kind B2 · utility
8Cited by
1References
10Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Nov 8, 2007 |
| Grant date | Oct 9, 2012 |
| Priority date | — |
| Expiry date | Dec 16, 2029 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/60
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The invention relates to kinase inhibitor ligands and polyligands. In particular, the invention relates to ligands and polyligands that modulate ERK activity. The ligands and polyligands are utilized as research tools or as therapeutics. The invention includes linkage of the ligands and polyligands to a cellular localization signal, epitope tag and/or a reporter. The invention also includes polynucleotides encoding the ligands and polyligands.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.